Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Apimeds Pharmaceuticals US, Inc. ( (APUS) ).
On May 30, 2025, Apimeds Pharmaceuticals US, Inc. appointed Erick J. Frim as the new Chief Financial Officer, succeeding Mark Corrao. Mr. Frim brings over 40 years of financial management experience, having previously served as Interim CFO at Helio Corporation and held significant roles at CFO Squad, LLC, SolomonEdwardsGroup, LLC, and EisnerAmper, LLP. His extensive background in financial operations and compliance is expected to strengthen the company’s financial leadership.
More about Apimeds Pharmaceuticals US, Inc.
Average Trading Volume: 211,552
See more insights into APUS stock on TipRanks’ Stock Analysis page.